Vir tus He alth (ASX. VRT ) Sue Channon CE O and Gle nn Powe r s CF O 2017 Mor gan Stanle y Austr alian E me r ging Companie s Confe r e nc e 15 th June , 2017
DISCL AIME R 2 T he ma te ria l in this pre se nta tio n ha s b e e n pre pa re d b y Virtus He a lth L imite d ABN 80 129 643 492 (“Virtus He a lth”) a nd is g e ne ra l b a c kg ro und info rma tio n a b o ut Virtus He a lth’ s a c tivitie s c urre nt a t the da te o f this pre se nta tio n. T he info rma tio n is g ive n in summa ry fo rm a nd inc lude s fina nc ia l a nd o the r info rma tio n a nd do e s no t purpo rt to b e c o mple te . Info rma tio n in this pre se nta tio n, inc luding fo re c a st fina nc ia l info rma tio n sho uld no t b e c o nside re d a s a dvic e o r a re c o mme nda tio n to inve sto rs o r po te ntia l inve sto rs a nd do e s no t ta ke into a c c o unt inve stme nt o b je c tive s, fina nc ia l situa tio n o r ne e ds o f a ny pa rtic ula r inve sto r. T he se sho uld b e c o nside re d, with o r witho ut pro fe ssio na l a dvic e whe n de c iding if a n inve stme nt is a ppro pria te . Pe rso ns ne e ding a dvic e sho uld c o nsult the ir sto c kb ro ke r, so lic ito r, a c c o unta nt o r o the r inde pe nde nt fina nc ia l a dviso r. T he re le a se , pub lic a tio n o r distrib utio n o f this pre se nta tio n in c e rta in jurisdic tio ns ma y b e re stric te d b y la w a nd the re fo re pe rso ns in suc h jurisdic tio ns into whic h this pre se nta tio n is re le a se d, pub lishe d o r distrib ute d sho uld info rm the mse lve s a b o ut a nd o b se rve suc h re stric tio ns. T his pre se nta tio n do e s no t c o nstitute , o r fo rm pa rt o f, a n o ffe r to se ll o r the so lic ita tio n o f a n o ffe r to sub sc rib e fo r o r b uy a ny se c uritie s, no r the so lic ita tio n o f a ny vo te o r a ppro va l in a ny jurisdic tio n, no r sha ll the re b e a ny sa le , issue o r tra nsfe r o f the se c uritie s re fe rre d to in this pre se nta tio n in a ny jurisdic tio n in c o ntra ve ntio n o f a pplic a b le la w. Ce rta in sta te me nts ma de in this pre se nta tio n a re fo rwa rd-lo o king sta te me nts. T he se fo rwa rd- lo o king sta te me nts a re no t histo ric a l fa c ts b ut ra the r a re b a se d o n Virtus He a lth L imite d’ s c urre nt e xpe c ta tio ns, e stima te s a nd pro je c tio ns a b o ut the industry in whic h Virtus He a lth o pe ra te s, a nd b e lie fs a nd a ssumptio ns. Wo rds suc h a s “a ntic ipa te s”, “e xpe c ts”, “inte nds,”, “pla ns”, “b e lie ve s”, “se e ks”, “e stima te s”, a nd simila r e xpre ssio ns a re inte nde d to ide ntify fo rwa rd-lo o king sta te me nts. T he se sta te me nts a re no t g ua ra nte e s o f future pe rfo rma nc e a nd a re sub je c t to kno wn a nd unkno wn risks, unc e rta intie s a nd o the r fa c to rs, so me o f whic h a re b e yo nd the c o ntro l o f Virtus He a lth, a re diffic ult to pre dic t a nd c o uld c a use a c tua l re sults to diffe r ma te ria lly fro m tho se e xpre sse d o r fo re c a ste d in the fo rwa rd-lo o king sta te me nts. Virtus He a lth c a utio ns inve sto rs a nd po te ntia l inve sto rs no t to pla c e undue re lia nc e o n the se fo rwa rd-lo o king sta te me nts, whic h re fle c t the vie w o f Virtus He a lth o nly a s o f the da te o f this pre se nta tio n. T he fo rwa rd-lo o king sta te me nts ma de in this pre se nta tio n re la te o nly to e ve nts a s o f the da te o n whic h the sta te me nts a re ma de . Virtus He a lth will no t unde rta ke a ny o b lig a tio n to re le a se pub lic ly a ny re visio ns o r upda te s to the se fo rwa rd-lo o king sta te me nts to re fle c t e ve nts, c irc umsta nc e s o r una ntic ipa te d e ve nts o c c urring a fte r the da te o f this pre se nta tio n e xc e pt a s re q uire d b y la w o r b y a ny a ppro pria te re g ula to ry a utho rity. A numb e r o f fig ure s, a mo unts, pe rc e nta g e s, e stima te s, c a lc ula tio ns o f va lue a nd fra c tio ns in this pre se nta tio n a re sub je c t to the e ffe c t o f ro unding . Ac c o rding ly, the a c tua l c a lc ula tio n o f the se fig ure s ma y diffe r fro m the fig ure s se t o ut in this pre se nta tio n. In a dditio n, a numb e r o f fig ure s ha ve b e e n c a lc ula te d o n the b a sis o f a ssume d e xc ha ng e ra te s, a s se t o ut in this pre se nta tio n. T o the ma ximum e xte nt pe rmitte d b y la w, ne ithe r Virtus He a lth no r its re la te d b o die s c o rpo ra te , dire c to rs, o ffic e rs, e mplo ye e s, a g e nts, c o ntra c to rs, a dvise rs no r a ny o the r pe rso n, a c c e pts, a nd e a c h e xpre ssly disc la ims, a ny lia b ility, inc luding witho ut limita tio n a ny lia b ility a rising fro m fa ult o r ne g lig e nc e , fo r a ny e rro rs o r missta te me nts in, o r o missio ns fro m, this pre se nta tio n o r a ny dire c t, indire c t o r c o nse q ue ntia l lo ss a rising fro m the use o f this pre se nta tio n o r its c o nte nts o r o the rwise a rising in c o nne c tio n with it.
One c hild in e ve ry Austra lia n c la ssro o m… 3
CONT E NT S 4 VIRT US HE AL T H Ove r vie w 5 E volution & Ne twor k of Ca r e 6 Our Pa tie nts & Se r vic e s 8 e a ding Sc ie nc e 11 L e a ding Minds, L F a c tor s Dr iving Gr owth 13 Ne a r T e r m Pr ior itie s 16 Innova tion – Adva nc e d T e c hnolog y 17 Str a te g ic Pla n 20
Y CARE VIRT US HE AL T H - WORL D L E ADE R IN F E RT IL IT 5 Mar ke t le ade r and lar ge st pr o vide r o f fe r tility se r vic e s in Austr alia and Ir e land with a gr o wing pr e se nc e in Singapo r e and De nmar k One of the la rg e st fe rtility pra c tic e s g loba lly F irst pub lic a lly liste d fe rtility b usine ss • Cha lle ng ing H1F Y17 prima rily due to do me stic c o nditio ns driving de c line in re ve nue & e a rning s • Gro up E BIIT DA do wn 12.3% to $31.7m (Austra lia n se g me nt do wn 13.1%; Inte rna tio na l se g me nt up 11.7% • o n pc p Re puta tion for c linic a l a nd sc ie ntific e xc e lle nc e 123 fe rtility spe c ia lists a nd o ve r 1200 pro fe ssio na l sta ff • Inve stme nt in c linic a l a nd sc ie ntific re se a rc h a nd ne w te c hno lo g ie s de live rs impro ve d pa tie nt • o utc o me s a nd g ro wth E a rly a do pte r o f ne w te c hno lo g ie s driving g ro wth • Distinc tive , dive rsifie d a nd ve rtic a lly inte g ra te d mode l with multiple sourc e s of re ve nue F e rtility, Da y Ho spita ls a nd Spe c ia lise d Dia g no stic s • * T o ta l tre a tme nts inc lude fre sh c yc le s, fro ze n e mb ryo tra nsfe rs a nd IUI s
E VOL UT ION OF VIRT US HE AL T H 6
VIRT US HE AL T H NE T WORK OF CARE 7 ASSIST E D SPE CIAL ISE D DAY RE PRODUCT IVE DIAGNOST ICS HOSPIT AL S SE RVICE S 46 62 6 F E RT IL IT Y CL INICS L ABORAT ORIE S DAY HOSPIT AL S Austra lia 41 E mb ryo lo g y 29 H H IVF a nd no n-IVF Ire la nd 3 And ro lo g y 27 pro c e d ure s Sing a po re 1 E nd o c rino lo g y 4 De nma rk 1 PGD 2 1042 227 123 NUR SE S, COUNSE L L OR S, SCIE NT IST S F E RT IL IT Y PAT IE NT SUPPOR T SPE CIAL IST S (inc l DIAGNOST ICS)
WHO COME S T O ASK F OR OUR HE L P? 8 40% o f the patie nts that se e fe r tility spe c ialists have no n IVF tr e atme nt
VIRT US T RE AT ME NT ANAL YSIS 9 T r e atme nt Mix Vir tus Cyc le s 9,782 9,410 1,272 8,448 1,340 15% 785 8,510 8,070 7,617 7,663 7,346 6,995 53% 32% HF Y12 HF Y13 HF Y14 HF Y15 HF Y16 HF Y17 Cyc le F ro ze n AI / OI Austra lia n Cyc le s I nte rna tio na l Cyc le s
DIVE RSIF IE D RE VE NUE MIX 10
NCE L E ADING MINDS, L E ADING SCIE 11 F o c us o n c linic al and sc ie ntific -le d inno vatio n and patie nt o utc o me s dr ive s lo ng te r m gr o wth I ndustry le a de r in fe rtility a nd sc ie ntific pra c tic e fo r o ve r • 30 ye a rs Re c o g nise d b ra nds re g a rde d fo r q ua lity a nd se rvic e • T ra c k re c o rd o f a ttra c ting a nd re ta ining hig h q ua lity • do c to rs, sc ie ntists & spe c ia list sta ff - inc re a sing numb e r o f pa tie nts T e c hno lo g y o f a dva nc e d sc ie nc e s, spe c ia lise d • dia g no stic s a nd inno va tio n de live rs impro ve d pa tie nt o utc o me s & re ve nue g ro wth E xpe rie nc e d c linic a l a nd ma na g e me nt te a m with • a b ility to drive pra c tic e g ro wth a nd a dd va lue
DOCT ORS OF VIRT US HE AL T H 12 One o f the mo st suc c e ssful me dic al c o llabo r atio ns inte r natio nally
Recommend
More recommend
